Kardiyak Glikozid Zehirlenmeleri

Yazarlar

Sinan Görgülü

Özet

Kardiyak glikozitler (dijitaller), esas olarak konjestif kalp yetmezliği ve atriyal fibrilasyon tedavisinde kullanılan, dar terapötik indekse sahip bitkisel kaynaklı ajanlardır. İleri yaş, kadın cinsiyeti, düşük yağsız vücut kütlesi ve böbrek yetmezliği gibi klinik faktörler serum ilaç seviyelerini artırarak toksisite riskini belirgin şekilde yükseltir. Farmakolojik olarak hücresel sodyum-potasyum-ATPaz pompasını inhibe eden kardiyak glikozitler, hücre içi kalsiyum birikimiyle inotropiyi artırırken aynı zamanda vagal tonusu da yükseltir. Toksisitenin klinik tablosu esas olarak prematüre ventriküler kasılmalar, bradikardi ve AV blok gibi kardiyak aritmilerle şekillenir; bununla birlikte anoreksi, bulantı, kusma, konfüzyon, halsizlik ve ksantopsi gibi görme bozukluklarını içeren gastrointestinal ve nörolojik semptomlar da görülür. Akut zehirlenmelerde hiperkalemi kritik bir mortalite göstergesiyken, kronik toksisite durumunda hipokalemi ve renal yetmezlik daha sık gözlenir. Tanı maruziyet öyküsü, EKG’deki sarkma tarzı ST depresyonu ve ritim bozuklukları ile serum digoksin düzeylerinin birlikte değerlendirilmesiyle konulur. Hastaların acil yönetiminde hava yolu, solunum ve sürekli kardiyak izlem ilk aşamayı oluşturur. Şiddetli vakalarda, hayatı tehdit eden aritmilerde veya yüksek potasyum seviyelerinde en temel ve etkili antidot tedavisi digoksine özgü antikor (Fab) fragmanlarının uygulanmasıdır. Erken dönemde aktif kömür veya kolestiramin yardımcı tedavi seçeneği sunarken, ilacın geniş dağılım hacmi nedeniyle hemodiyaliz ya da hemoperfüzyon yöntemlerinin zehirlenme tedavisinde yeri yoktur.

Cardiac glycosides (digitalis) are plant-derived agents with a narrow therapeutic index, primarily used in the treatment of congestive heart failure and atrial fibrillation. Clinical factors such as advanced age, female sex, low lean body mass, and renal impairment significantly increase the risk of toxicity by elevating serum drug levels. Pharmacologically, cardiac glycosides inhibit the cellular sodium-potassium-ATPase pump, increasing inotropy through intracellular calcium accumulation while simultaneously raising vagal tone. The clinical presentation of toxicity is mainly characterized by cardiac arrhythmias such as premature ventricular contractions, bradycardia, and AV block; however, gastrointestinal and neurological symptoms, including anorexia, nausea, vomiting, confusion, weakness, and visual disturbances such as xanthopsia, can also occur. While hyperkalemia serves as a critical indicator of mortality in acute poisonings, hypokalemia and renal impairment are more frequently observed in chronic toxicity. Diagnosis is established by evaluating the exposure history, ECG changes such as sagging ST-segment depression and dysrhythmias, along with serum digoxin levels. Initial management of patients involves airway, breathing, and continuous cardiac monitoring. In severe cases, life-threatening arrhythmias, or elevated potassium levels, the primary and most effective antidote therapy is the administration of digoxin-specific antibody (Fab) fragments. Although activated charcoal or cholestyramine offers an adjunctive treatment option in the early stages, hemodialysis or hemoperfusion has no role in the management of toxicity due to the drug's large volume of distribution.

Referanslar

Birkenhäger, W.H. and J.A.J.P.i.C.D. Staessen, Progress in cardiovascular diseases: cognitive function in essential hypertension. 2006. 49(1): p. 1-10.

Yang, E.H., S. Shah, and J.M.J.T.A.j.o.m. Criley, Digitalis toxicity: a fading but crucial complication to recognize. 2012. 125(4): p. 337-343.

Smith, T.W.J.N.E.J.o.M., Digitalis: mechanisms of action and clinical use. 1988. 318(6): p. 358-365.

Levine, M., H. Nikkanen, and D.J.J.T.J.o.E.M. Pallin, The effects of intravenous calcium in patients with digoxin toxicity. 2011. 40(1): p. 41-46.

Demiryürek, A., S.J.A. Demiryürek, and a. pharmacology, Cardiotoxicity of digitalis glycosides: roles of autonomic pathways, autacoids and ion channels. 2005. 25(2): p. 35-52.

Ma, G., et al., Electrocardiographic manifestations: digitalis toxicity. 2001. 20(2): p. 145-152.

Ribner, H.S., et al., Acute effects of digoxin on total systemic vascular resistance in congestive heart failure due to dilated cardiomyopathy: a hemodynamic-hormonal study. 1985. 56(13): p. 896-904.

Lip, G., M.J. Metcalfe, and F.G.J.P.m.j. Dunn, Diagnosis and treatment of digoxin toxicity. 1993. 69(811): p. 337.

Chan, B. and N.J.C.t. Buckley, Digoxin-specific antibody fragments in the treatment of digoxin toxicity. 2014. 52(8): p. 824-836.

Greiner, B., et al., The role of intestinal P-glycoprotein in the interaction of digoxin and rifampin. 1999. 104(2): p. 147-153.

Brubacher, J., et al., Efficacy of digoxin specific Fab fragments (Digibind®) in the treatment of toad venom poisoning. 1999. 37(6): p. 931-942.

Bhatia, S.J.W.J.o.M., Digitalis toxicity--turning over a new leaf? 1986. 145(1): p. 74.

Aronson, J.J.C.p., Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction. 1983. 8(2): p. 155-178.

Li-Saw-Hee, F. and G.J.Q.m.j.o.t.A.o.P. Lip, Digoxin revisited. 1998. 91(4): p. 259-264.

Muñoz, N.L., A.B. Buendía, and F.A.J.T.o.c.m.j. Manterola, Electrocardiographic Changes After Suicidal Digoxin Intoxication in a Healthy Woman. 2017. 11(1).

Lounsbury, H.T. and S.O.J.E.i.C.M. Althoff, The ECG in Environmental Urgencies and Emergencies. 2020: p. 315-325.

Kelly, R.A. and T.W.J.T.A.j.o.c. Smith, Recognition and management of digitalis toxicity. 1992. 69(18): p. 108-119.

Briggs, B., Van Gogh Vision: Digoxin Toxicity.

De Silva, H., et al., Multiple-dose activated charcoal for treatment of yellow oleander poisoning: a single-blind, randomised, placebo-controlled trial. 2003. 361(9373): p. 1935-1938.

Eddleston, M., et al., Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial. 2008. 371(9612): p. 579-587.

Henderson, R.P. and C.P.J.A.o.i.m. Solomon, Use of cholestyramine in the treatment of digoxin intoxication. 1988. 148(3): p. 745-746.

İndir

Yayınlanan

6 Nisan 2021

Lisans

Lisans